These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35256323)

  • 1. Recommendations on the use of intravesical hyaluronic acid instillations in bladder pain syndrome.
    Madurga Patuel B; González-López R; Resel Folkersma L; Machado Fernández G; Adot Zurbano JM; Bonillo MÁ; Vozmediano Chicharro R; Zubiaur Líbano C
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):131-137. PubMed ID: 35256323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and safety of intravesical hyaluronic acid for symptom control in chronic bladder diseases.].
    Boronat Catalá J; García Tello A; González Montes L; Ruiz Graña S; Torres Pérez D; Llanes González L
    Arch Esp Urol; 2021 Sep; 74(7):639-644. PubMed ID: 34472431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.
    Scarneciu I; Bungau S; Lupu AM; Scarneciu CC; Bratu OG; Martha O; Tit DM; Aleya L; Lupu S
    Eur J Pharm Sci; 2019 Nov; 139():105067. PubMed ID: 31499170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up.
    Imperatore V; Creta M; Di Meo S; Buonopane R; Longo N; Fusco F; Spirito L; Imbimbo C; Mirone V
    Arch Ital Urol Androl; 2018 Mar; 90(1):11-14. PubMed ID: 29633792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder instillation patterns in a cohort of women with interstitial cystitis/bladder pain syndrome.
    Niino CA; Tholemeier LN; Bresee C; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT
    Urogynecology (Phila); 2023 Nov; 29(11):914-919. PubMed ID: 38107872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis.
    Leppilahti M; Hellström P; Tammela TL
    Urology; 2002 Jul; 60(1):46-51. PubMed ID: 12100920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis.
    Porru D; Leva F; Parmigiani A; Barletta D; Choussos D; Gardella B; Daccò MD; Nappi RE; Allegri M; Tinelli C; Bianchi CM; Spinillo A; Rovereto B
    Int Urogynecol J; 2012 Sep; 23(9):1193-9. PubMed ID: 21904840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis.
    Barua JM; Arance I; Angulo JC; Riedl CR
    Int Urogynecol J; 2016 Aug; 27(8):1137-47. PubMed ID: 26590137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
    Jiang YH; Liu HT; Kuo HC
    PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model.
    Sahiner IF; Soylu H; Ates E; Acar N; Ustunel I; Danisman A
    Int Braz J Urol; 2018; 44(5):1014-1022. PubMed ID: 30044599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.